Stem Cells Pass Initial Safety Muster in ALS, Multiple Sclerosis
Amidst all the promise of stem cell technology, there is also a heaping share of worry...
6377 RESULTS
Sort By:
Amidst all the promise of stem cell technology, there is also a heaping share of worry...
There is evidence that Aβ can go from the blood to the brain...
Could the field be one step closer to a new potential therapy for AD? Possibly, if the target is striatal-enriched tyrosine phosphatase (STEP)...
Mutated superoxide dismutase 1 contorts itself into strange and unnatural shapes, leading to amyotrophic lateral sclerosis...
A $40 million multicenter biomarker study for Parkinson disease progression is off and running, with enrollment underway at 10 of 18 sites in the U.S. and Europe. In design and operation, the Parkinson's Progression Markers Initiative (PPMI) follow
PPMI was launched in July with hopes of identifying a biomarker, or set of markers, that tracks the natural course of Parkinson disease...
One of the great challenges with developing treatments for neurodegenerative disorders stems from the capricious nature of disease progression...
Hard on the heels of a recent debate about the value of preventive measures for Alzheimer disease (AD) come some new data on physical activity...
Is apoptosis is a core process early in ALS, or merely the swan song of cells that have lost the ability to do anything other than make a graceful exit...
Gene therapy is an important research strategy and carries hope of becoming a viable treatment in neurodegenerative disease...
Two Faces of Evil: Cancer and Neurodegeneration Ipsen Colloquium on Alzheimer's Disease
Cancer and neurodegenerative diseases—what do they have in common, apart from the distress they cause to sufferers and their families?...
Researchers report that PGC-1α manages multiple genes that mitochondria need for biogenesis, electron transport, and glucose metabolism...
Immune cells cannot easily cross the blood-brain barrier to enter the central nervous system, but when they do reach the brain to fight infection, they don’t let go...
A report published online October 3 in Nature Genetics adds to the evidence for functional variants in NMDA glutamate receptor genes...